Skip over main navigation
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patron
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • About neuroblastoma
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Neuroblastoma treatment
  • Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2020
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Funding award process
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Support Our Work
    • Donate now
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)
  • Neuroblastoma Parent Global Symposium 2020
  1. Support
  2. Neuroblastoma Parent Education Conference

Neuroblastoma Parent Global Symposium 2020

On 6-7 November 2020 the inaugural Neuroblastoma Parent Global Symposium brought together families affected by neuroblastoma from around the world with those who work to treat, help and support them. 

Presentations from 36 experts from Australia, North America, and Europe shared the latest information on biology, treatment, research, late effects, and psychosocial challenges surrounding a childhood cancer diagnosis. Over 750 parents, medical professionals, charity leaders, and industry representatives from 47 countries were able to view live presentations, panel sessions, and ask questions.   

Families worldwide now have free access to information through 25 hours of recorded sessions which all can be viewed at www.nbparentsymposium.com.

International experts delivered sessions providing credible and reliable information on treatment and clinical trials, including current treatment strategies in Europe, North America and Australia, and some of the impacts of a childhood cancer diagnosis on the whole family.  

A prestigious Clinical Steering Committee oversaw the development of the comprehensive program, and was chaired by Daniel Morgenstern, MD. CSC members were Ami Dasai, MD, Cormac Owens, MD, Juliet Grey, MA, MB, BS, PhD, Lucas Moreno, MD, PhD, Michelle Haber, BSc, PhD, Navin Pinto, MD, Steven DuBois, MD, MS, Thorsten Simon MD, and Toby Trahair, MD. 

Ahead of the event Dr. Lucas Moreno, member of the Clinical Steering Committee, said of the Symposium, “I strongly encourage families from all over the world to join this unique event. The event includes presentations of new advances in treatment, educational sessions, talks covering psychosocial aspects and how to facilitate access to innovative medicines.” 

Solving Kids’ Cancer UK has collaborated with Children’s Neuroblastoma Cancer Foundation and Solving Kids’ Cancer (US) (two charities with whom we have a history of collaboration) on this world-wide event - the first of its kind for the international neuroblastoma community.  

We are grateful to GRC World Forums, Y-mAbs Therapeutics, THANC Foundation,  Sanofi and United Therapeutics for their support to help make this event possible. 

About the Symposium Partners 

Children’s Neuroblastoma Cancer Foundation 

The Children’s Neuroblastoma Cancer Foundation (CNCF) is the premier source for neuroblastoma information and resources.  

Comprised of families just like yours, we are committed to finding a cure for neuroblastoma through research, education, awareness and advocacy. Visit www.cncfhope.org to find out more about the work of CNCF. 

Solving Kids’ Cancer 


We are a 
parent-led charity, our vision is for future where no child dies of neuroblastoma or suffers due to its treatment. 

As part of our mission Solving Kids’ Cancer initiates and funds innovative clinical research to provide children with the best and most promising new therapies available closer to home. Our research focus is on clinical trials, seeking to explore new ways of treating neuroblastoma, providing hope and options for children and their families now as well as building on the scientific understanding of this disease for children in the future. 

Solving Kids’ Cancer US 


Solving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates - because Every Kid Deserves to Grow Up. 
 

Solving Kids' Cancer helps accelerate new clinical trials of next-generation treatments including immunotherapy,  biomarker-based targeted agents, and new combination therapies through research advocacy, with an understanding of the childhood cancer research landscape and current unmet needs to wisely invest in innovative projects.  Visit www.solvingkidcancer.org to learn more. 













Published: 12th August, 2020

Updated: 1st February, 2021

Author: Anne Denman

Related topics:
  • Conferences
Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • 100 miles for Henry In March

    100 miles for Henry In March

    Henry is such a strong an amazing little boy, a real inspiration at such a young age. I want to try and help him and his family reach their goal to continue his treatment.

  • Research Explainer: Single Cell Study Finds Sympathoblasts as the Root of Neuroblastoma

    Research Explainer: Single Cell Study Finds Sympathoblasts as the Root of Neuroblastoma

    Last month, researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital and Princess Máxima Centre published a new single cell study that has shown all neuroblastomas arise from one type of developmental cell called sympathoblasts. We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.

  • Karen and Evie’s 23 day Squatty Botty

    Karen and Evie’s 23 day Squatty Botty

    We are taking on the Squatty Botty challenge to raise much needed funds for dear little Ollie

  • Leeanne Brennan

Related

  • 2019 Neuroblastoma Parent Conference

    2019 Neuroblastoma Parent Conference

    2019 Solving Kids’ Cancer Neuroblastoma Parent Education Conference.

  • 2018 Neuroblastoma Parent Education Conference

    2018 Neuroblastoma Parent Education Conference

    Our 2018 conference offered a concurrent session focusing on ways to deal with and manage the long-term side effects of neuroblastoma.

  • 2017 Neuroblastoma Parent Education Conference

    2017 Neuroblastoma Parent Education Conference

    Our 6th Annual Neuroblastoma Parent Education Conference – ‘Understanding the Landscape of Neuroblastoma Research’

  • 2016 Neuroblastoma Parent Education Conference

    2016 Neuroblastoma Parent Education Conference

    Our 5th Annual Neuroblastoma Parent Education Conference was held at Latimer Place in Chesham

  • 2015 Neuroblastoma Parent Education Conference

    2015 Neuroblastoma Parent Education Conference

    Our 4th Annual Parent Conference was again held at Latimer Place, Chesham

Most read

  • Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

  • Corey is thriving after neuroblastoma battle

    Corey is thriving after neuroblastoma battle

    Family donate almost £150,000 to neuroblastoma research

  • Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

  • BEACON study opens in Europe

    BEACON study opens in Europe

    The much-anticipated BEACON study amendment is now open and recruiting patients.

  • Steve Richards to step down as Chief Executive

    Steve Richards to step down as Chief Executive

    CEO to leave Solving Kids' Cancer after three years in the role.

  • Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

  • Charities fund new clinical trial

    Charities fund new clinical trial

    Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

  • First Three Months

    First Three Months

    Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

  • Ewen's Journey

    Ewen's Journey

    Ewen sadly passed away on 28th September 2020.

  • Neuroblastoma Parent Global Symposium 2020

    Neuroblastoma Parent Global Symposium 2020

    Neuroblastoma Parent Global Symposium 2020

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.